Ratcliffe Liam bought OKUR
June 4, 2026 · Form 4 insider transaction
Ratcliffe Liam bought 1,275 shares of OnKure Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,275
Price
$0.00
Total value
N/A
InsiderRatcliffe Liam
RoleDirector
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJune 4, 2026
Filing dateJune 8, 2026
Shares owned after1,275
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
100% of the shares subject to the option will vest on the earlier of June 4, 2027 or the day prior to the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through the applicable vesting date.